The Emerald Groundhog Day Investment Forum marks its 22nd annual event on February 5th in Philadelphia, PA with over 20 companies scheduled to present.

Emerald Asset Management, Inc. will welcome hundreds of investment industry professionals to the 22nd annual Emerald Groundhog Day Investment Forum, scheduled to be held on Thursday, February 5th at the Radisson Blu Warwick Hotel in Philadelphia, PA. “Each year we say that the investment year begins in earnest with our annual Forum,” said Emerald CEO and Founder Joseph E. Besecker. “This year with increased market volatility and an uncertain economic outlook, hearing directly from corporate leaders and our team of analysts and portfolio managers is even more imperative,” he said. Public company senior managers, investment portfolio managers and research analysts come together to review 2014 and provide their initial outlook to 2015 and beyond. This year’s Forum will include sessions focusing on cyber security, advances in biotechnology, community and regional banks, income-oriented and alternative investments and ongoing innovations by corporate America generating potential investment opportunities.

The first Emerald Groundhog Day Investment Forum was held in 1994 and has grown to become the definitive kick-off conference for investors focusing on small- and mid-cap companies. This year senior executives from over twenty public and private companies and Emerald are scheduled to present, including Emerald’s “Outlook for Growth - 2015.” “The U.S. economy has thus far avoided much of the malaise affecting other global economies,” said Emerald Director of Research Joseph W. Garner. “Will our leadership continue? The Forum provides a great chance to hear how presenting companies are positioned moving forward and what they are seeing in terms of growth and opportunities,” he said.

Presenting companies are scheduled to include: Actua Corp. (ACTA), Alnylam Pharmaceuticals (ALNY), Apogee Enterprises (APOG), Aqua America (WTR), Bryn Mawr Bank Corp. (BMTC), Customers Bancorp (CUBI), EPAM Systems (EPAM), GSV Capital (GSVC), Inovio Pharmaceuticals (INO), Marinus Pharmaceuticals (MRNS), Matthews International (MATW), Quaker Chemical (KWR), Royal Bancshares of Pennsylvania (RBPAA), S&T Bancorp (STBA), Safeguard Scientifics (SFE), Sanchez Energy (SN), Sandy Spring Bancorp (SASR), StoneMor Partners (STON) and Trex Company (TREX), as well as the team of portfolio managers and analysts from Emerald providing their outlook for 2015 and the annual economic outlook presented by noted economist Joel Naroff. A full list of presenting companies, seminars by Emerald’s investment professionals and registration details are available on Emerald’s website at www.TeamEmerald.com/groundhog.

Presented by Emerald Asset Management, Forum sponsors include Pepper Hamilton LLP, Janney Capital Markets, Boenning & Scattergood, Greentree, Trout, Ebersole & Groff LLP, and Sturdivant & Co.

Founded in 1991, Emerald Asset Management, Inc. is a diversified investment management company that operates thru its subsidiaries Emerald Advisers, Inc., Emerald Mutual Fund Advisers Trust, Emerald Separate Account Management, LLC, Emerald Fixed Income Advisers, LLC and Emerald Direct Lending Advisers, LLC. Assets managed by these companies totaled over $3.2 billion as of December 31, 2014. “Driven by Research,” Emerald is an asset management firm providing research-based growth-oriented and income-producing portfolio management services for institutions and individuals.

Emerald Asset Management, Inc.Emerald Advisers, Inc.Emerald Fixed Income Advisers LLCEmerald Mutual Fund Advisers TrustEmerald Separate Account Management LLCEmerald Direct Lending Advisers LLC3175 Oregon PikeLeola, PA 17540717.556.8900800.722.4123King of Prussia, PAPittsburgh, PAOceanside, CAwww.TeamEmerald.com

Emerald Advisers, Inc.Joseph W. Garner, 717-556-8900

Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alnylam Pharmaceuticals Charts.
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alnylam Pharmaceuticals Charts.